NYSE · GRDN
Healthcare · Medical - Distribution
$40.87
Up+$1.22 (+2.99%)
Updated Nov 4, 2026, 11:03 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · GRDN
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
GRDN closed at $40.87 after 21 trading sessions, down 0.80% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $40.00 | $40.97 | $39.79 | $40.87 | 496.55K |
| Nov 2, 2026 | $40.50 | $40.565 | $39.71 | $40.00 | 410.3K |
| Oct 30, 2026 | $40.98 | $41.37 | $40.255 | $40.69 | 318.98K |
| Oct 29, 2026 | $40.78 | $41.11 | $40.16 | $40.45 | 207.98K |
| Oct 28, 2026 | $39.29 | $40.48 | $39.06 | $40.33 | 235.45K |
| Oct 27, 2026 | $39.24 | $39.9316 | $38.85 | $39.56 | 357.12K |
| Oct 26, 2026 | $39.74 | $40.17 | $38.855 | $39.19 | 212.15K |
| Oct 23, 2026 | $39.41 | $39.63 | $39.0225 | $39.44 | 242.07K |
| Oct 22, 2026 | $39.38 | $39.9699 | $39.27 | $39.59 | 252.89K |
| Oct 21, 2026 | $41.58 | $41.99 | $38.91 | $38.98 | 429.33K |
| Oct 20, 2026 | $40.39 | $42.26 | $39.665 | $41.87 | 591.41K |
| Oct 19, 2026 | $39.71 | $40.40 | $39.41 | $40.14 | 378.65K |
| Oct 16, 2026 | $39.68 | $39.86 | $39.07 | $39.47 | 426.04K |
| Oct 15, 2026 | $40.87 | $41.215 | $39.26 | $39.68 | 444K |
| Oct 14, 2026 | $39.56 | $40.59 | $39.30 | $40.58 | 390.67K |
| Oct 13, 2026 | $40.77 | $40.77 | $39.63 | $39.81 | 300.43K |
| Oct 12, 2026 | $40.61 | $40.61 | $39.13 | $40.47 | 733.19K |
| Oct 9, 2026 | $41.43 | $41.475 | $40.67 | $41.28 | 397.51K |
| Oct 8, 2026 | $40.79 | $41.80 | $40.19 | $41.60 | 574.11K |
| Oct 7, 2026 | $40.77 | $41.98 | $40.35 | $40.68 | 388.31K |
| Oct 6, 2026 | $42.30 | $42.95 | $40.80 | $41.20 | 388.63K |
The latest Smart Investors Daily articles mentioning GRDN.
Company
Market Activity
Research & News
GRDN research
Company profile and research snapshot.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | Keybanc | Overweight | — |
| Sep 21, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Oppenheimer | Outperform | — |
| Jun 17, 2026 | Truist Securities | Buy | — |
| Jun 17, 2026 | B of A Securities | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 2, 2026
ATLANTA, November 02, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Van’s Institutional Pharmacy, a long-term care pharmacy based in Martin, Tennessee.
Yahoo · Nov 2, 2026
ATLANTA, November 02, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will attend the Stephens Investment Conference in Nashville, TN, on Wednesday, November 18, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 9:30 a.m. Central Standard Time.
Yahoo · Oct 25, 2026
Guardian Pharmacy Services has had a strong run over the past year, which puts fresh attention on a simple question for investors: Is the current share price aligned with what the business can generate in cash over time, based on its underlying pharmacy operations and recent developments? The stock has gained 38.2% over the past year, which raises the stakes on whether that move is matched by the cash flows that ultimately underpin its intrinsic value. Recent corporate updates highlight...
Yahoo · Oct 21, 2026
ATLANTA, October 21, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release third quarter 2026 financial results after market close on Thursday, November 5, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning GRDN.
